Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment and Response Assessment Period	STARTED	Placebo	176
Treatment and Response Assessment Period	STARTED	KX2-391 Ointment 1%	175
Treatment and Response Assessment Period	COMPLETED	Placebo	174
Treatment and Response Assessment Period	COMPLETED	KX2-391 Ointment 1%	175
Treatment and Response Assessment Period	NOT COMPLETED	Placebo	2
Treatment and Response Assessment Period	NOT COMPLETED	KX2-391 Ointment 1%	0
Recurrence Follow-up Period	STARTED	Placebo	8
Recurrence Follow-up Period	STARTED	KX2-391 Ointment 1%	77
Recurrence Follow-up Period	COMPLETED	Placebo	2
Recurrence Follow-up Period	COMPLETED	KX2-391 Ointment 1%	22
Recurrence Follow-up Period	NOT COMPLETED	Placebo	6
Recurrence Follow-up Period	NOT COMPLETED	KX2-391 Ointment 1%	55

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03285477/flow